Cargando…
The Neuroprotective Properties of the Amyloid Precursor Protein Following Traumatic Brain Injury
Despite the significant health and economic burden that traumatic brain injury (TBI) places on society, the development of successful therapeutic agents have to date not translated into efficacious therapies in human clinical trials. Injury to the brain is ongoing after TBI, through a complex cascad...
Autores principales: | Plummer, Stephanie, Van den Heuvel, Corinna, Thornton, Emma, Corrigan, Frances, Cappai, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809608/ https://www.ncbi.nlm.nih.gov/pubmed/27114849 http://dx.doi.org/10.14336/AD.2015.0907 |
Ejemplares similares
-
The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury
por: Plummer, Stephanie L., et al.
Publicado: (2018) -
Evaluating spatiotemporal microstructural alterations following diffuse traumatic brain injury
por: Mohamed, Abdalla Z, et al.
Publicado: (2019) -
Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury
por: Roehl, Anna B, et al.
Publicado: (2010) -
Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
por: Aychman, Mackenzie M., et al.
Publicado: (2023) -
Short and Long Term Behavioral and Pathological Changes in a Novel Rodent Model of Repetitive Mild Traumatic Brain Injury
por: McAteer, Kelly M., et al.
Publicado: (2016)